Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dirk Karel Maria De Ruysscher"'
Autor:
Anne-Marie C. Dingemans, Dirk Karel Maria De Ruysscher, Lizza E.L. Hendriks, Janna Schoenmaekers, Safiye Dursun, Charlotte Biesmans, Jordi Remon, Martinus P.G. Broen
Publikováno v:
Critical Reviews in Oncology/Hematology. 166
Although central nervous system (CNS) metastases frequently occur in patients with non-small cell lung cancer (NSCLC), historically these patients have been excluded from clinical trials. However, due to improving NSCLC prognosis, time to develop CNS
Autor:
M.J.J. Voorn, R.F.W. Franssen, J.M.W.F. Verlinden, Bart C. Bongers, Maryska L.G. Janssen-Heijnen, G. Bootsma, Dirk Karel Maria De Ruysscher
Publikováno v:
Critical reviews in oncology/hematology. 158
This systematic review evaluated which outcome variables and cut-off values of pretreatment exercise tests are associated with treatment complications in patients with stage I-III non-small cell lung cancer (NSCLC). PRISMA and Cochrane guidelines wer
Autor:
Béranger Lueza, Lesley Seymour, C. Le Pechoux, Minoru Takada, Allan Price, S. Spiro, M. Pijls-Johannesma, M. O'Brien, Anne-Sophie Veillard, N. Murray, Nevin Murray, M. Takada, Taro Shibata, James Lovato, H. Choy, David H. Johnson, W. Blackstock, Jeffrey Crawford, Cécile Le Péchoux, Donald H. Johnson, J.P. Pignon, D.V. Skarlos, Jean-Pierre Pignon, William Blackstock, Mary O’Brien, Anne Sophie Veillard, Dirk Karel Maria De Ruysscher, Hak Choy, Baktiar Hasan, X. Wang, Bernard Lebeau, Urania Dafni, E. Paris, Suzanne E. Dahlberg, B. Lebeau, Madelon Pijls-Johannesma, Sylvie Chevret, Xiaofei Wang, Dirk De Ruysscher, L. Seymour, R. Arriagada, Emmanuelle Paris, Dimosthenis Skarlos, Allan Hackshaw, P. Baas, A. Price, Stephen G. Spiro, Rodrigo Arriagada, Paul Baas
Publikováno v:
Annals of Oncology
Annals of Oncology, Elsevier, 2016, 27 (10), pp.1818-1828. ⟨10.1093/annonc/mdw263⟩
Annals of Oncology, 2016, 27 (10), pp.1818-1828. ⟨10.1093/annonc/mdw263⟩
Annals of Oncology, Elsevier, 2016, 27 (10), pp.1818-1828. ⟨10.1093/annonc/mdw263⟩
Annals of Oncology, 2016, 27 (10), pp.1818-1828. ⟨10.1093/annonc/mdw263⟩
International audience; BackgroundChemotherapy combined with radiotherapy is the standard treatment of “limited-stage” small-cell lung cancer. However, controversy persists over the optimal timing of thoracic radiotherapy and chemotherapy.Materia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c89b1669f60e81e5d43f7f690e3ca5a4
https://europepmc.org/articles/PMC5035783/
https://europepmc.org/articles/PMC5035783/